Reason for Hope, et al. Provide Comments on FDA Draft Guidance for Clinical Investigation of Psychedelic Drugs
- Reason for Hope
- Aug 25, 2023
- 1 min read
Reason for Hope, The Veteran Mental Health Leadership Coalition, BrainFutures, and the additional cosigners noted below provided comments on the draft guidance, Psychedelic Drugs: Considerations for Clinical Investigations / Guidance For Industry (“draft Guidance”), which the Food and Drug Administration (“FDA”) announced in the Federal Register on June 26, 2023.
